Logo Logo
Hilfe
Hilfe
Switch Language to English

Garnier, Laure; Pick, Robert; Montorfani, Julien; Sun, Mengzhu; Brighouse, Dale; Liaudet, Nicolas; Kammertoens, Thomas; Blankenstein, Thomas; Page, Nicolas; Bernier-Latamani, Jeremiah; Tran, Ngoc Lan; Petrova, Tatiana V.; Merkler, Doron; Scheiermann, Christoph und Hugues, Stephanie (2022): IFN-gamma-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis. In: Science Advances, Bd. 8, Nr. 23, eabl5162

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Tumor-associated lymphatic vessels promote metastasis and regulate antitumor immune responses. Here, we assessed the impact of cytotoxic T cells on the local lymphatic vasculature and concomitant tumor dissemination during an antitumor response. Interferon-gamma (IFN-gamma) released by effector T cells enhanced the expression of immunosuppressive markers by tumor-associated lymphatic endothelial cells (LECs). However, at higher effector T cell densities within the tumor, T cell-based immunotherapies induced LEC apoptosis and decreased tumor lymphatic vessel density. As a consequence, lymphatic flow was impaired, and lymph node metastasis was reduced. Mechanistically, T cell-mediated tumor cell death induced the release of tumor antigens and cross-presentation by tumor LECs, resulting in antigen-specific LEC killing by T cells. When LECs lacked the IFN-gamma receptor expression, LEC killing was abrogated, indicating that IFN-gamma is indispensable for reducing tumor-associated lymphatic vessel density and drainage. This study provides insight into how cytotoxic T cells modulate tumor lymphatic vessels and may help to improve immunotherapeutic protocols.

Dokument bearbeiten Dokument bearbeiten